Can You Have a Dental Implant If You Have Had Radiotherapy to the Head or Neck?

People who have completed treatment for head and neck cancer often arrive at a dental consultation carrying two things at once: a strong wish to get their mouth back to something resembling normal, and a well-founded caution about anything that involves surgery in the jaw. Both are reasonable. Missing teeth after cancer treatment affect eating, speech and confidence in ways that are far from cosmetic, and yet the tissue in which any implant would be placed has been fundamentally altered.

The short answer to the question in the title is that implants are sometimes possible, that the decision is more involved than in a patient who has not had radiotherapy, and that it should never be made by a dental team working in isolation from the oncology team.

This article sets out what radiotherapy actually does to the tissues, what influences the outcome, and how planning and protocols are adjusted. It is intended to help you have a more informed conversation, not to indicate what is right for your particular situation.

Is previous radiotherapy an absolute barrier to dental implants?

Previous radiotherapy is not an absolute barrier, but it is a significant modifying factor that changes how suitability is judged, how surgery is planned and how healing is monitored. Whether implants can be considered depends on the radiation dose delivered to the specific area of jaw involved, the time that has elapsed since treatment finished, which jaw is being considered, the condition of the overlying soft tissue, and the patient's general health and smoking status. Some patients are appropriate candidates with modified protocols. Others are better served by removable prostheses because the risk of a serious healing complication outweighs the functional benefit. This judgement requires imaging, the radiotherapy treatment records, and input from the oncology team.

Therapeutic radiation is directed at tumour tissue, but bone and soft tissue within the treatment field are affected too. Several changes are relevant to implant treatment.

Radiation damages the small blood vessels within bone and soft tissue. Over the months and years following treatment the vasculature becomes progressively less able to deliver oxygen, nutrients and immune cells. Bone healing depends entirely on this supply, and implant integration is a healing process.

The population of bone-forming and bone-remodelling cells is depleted. Irradiated bone is therefore less able to respond to injury, and remodelling around an implant proceeds more slowly and less predictably.

Soft tissues within the field become less elastic and more fibrous over time. This affects surgical access, flap design, wound closure and the quality of the tissue that must seal around an implant.

Salivary glands within the treatment field are frequently affected, producing lasting dryness. Saliva buffers acid, clears debris and provides antimicrobial protection. Its loss substantially increases the risk of decay and of soft tissue problems, and complicates the wearing of any prosthesis.

The most serious concern is osteoradionecrosis — an area of irradiated bone that fails to heal and becomes exposed. It can be triggered by surgery, extraction or trauma in a previously irradiated field, and it is a difficult condition to manage. The risk relates strongly to radiation dose to that site, and is generally recognised to be higher in the mandible than the maxilla because of its denser structure and comparatively limited blood supply.

Assessment focuses on a number of specific variables.

• Radiation dose to the proposed site. This is the single most informative piece of data, and it comes from the radiotherapy treatment plan rather than from a dental examination. Doses vary considerably across the field; one region of the jaw may have received a fraction of what another received.

• Time since radiotherapy. Tissue changes evolve over time. There is a period immediately after treatment during which elective surgery is generally avoided, and clinicians also consider that vascular changes are progressive in the longer term. Timing is judged case by case.

• Which jaw. The maxilla generally has a more favourable blood supply than the mandible.

• Smoking. Smoking further compromises an already reduced blood supply and materially increases the risk of complications. Cessation is typically a prerequisite for considering surgery.

• Soft tissue condition. Fibrotic, thin or previously grafted tissue affects closure and long-term maintenance.

• Bone volume and quality. Assessed with cone beam imaging. Grafting in irradiated bone is considerably less predictable than in non-irradiated bone.

• Oral hygiene and dexterity. Maintenance demands are higher in a dry mouth, and the consequences of poor hygiene are more serious.

• Medications. Some patients will also have received antiresorptive or antiangiogenic drugs, which carry their own considerations for jaw surgery.

• The patient's overall prognosis and priorities. Function, comfort and treatment burden all have to be weighed realistically.

Where implants are considered appropriate, protocols are commonly adapted.

• Detailed imaging and planning. Cone beam CT combined with the radiotherapy dose map allows sites to be selected in regions that received lower doses where possible.

• Site selection rather than ideal positioning. Implant positions may be chosen for biological safety rather than for the most convenient prosthetic position, with the prosthesis designed around them.

• Fewer, longer-healing implants. Extended healing periods before loading are usual, as integration in irradiated bone proceeds more slowly.

• Atraumatic surgical technique. Minimising heat generation, periosteal stripping and flap tension reduces the insult to a compromised healing environment.

• Avoidance of extensive grafting. Where volume is inadequate, a removable prosthesis may be preferred to an ambitious reconstruction.

• Antibiotic and adjunctive protocols. Some centres use specific perioperative regimens; adjunctive measures such as hyperbaric oxygen have been used historically and remain a matter of ongoing clinical debate rather than settled practice.

• Prosthesis design for cleanability. Designs that allow access for cleaning are prioritised over designs that are easier to make.

• Close, frequent review. Monitoring intervals are shorter than for a standard implant patient.

Alternatives always deserve equal consideration. A well-made removable prosthesis can restore a great deal of function while avoiding surgery altogether — see our page on dentures. Where teeth adjacent to a space are sound, a conventional or Maryland bridge may be an option. Our overview of dental implants explains the standard pathway for comparison.

Whether or not implants are pursued, the oral environment after head and neck radiotherapy needs active management.

• Managing dry mouth. Frequent sips of water, saliva substitutes and avoidance of alcohol-containing mouthwashes. Sugar-free products only — dry mouth combined with sugary lozenges is a well-recognised route to rapid decay.

• High-fluoride toothpaste. Commonly prescribed for patients with reduced saliva.

• Meticulous plaque control. Decay progresses faster and more extensively without salivary protection. Our article on deep decay reaching the nerve explains why early detection matters so much.

• Frequent professional review. Shorter recall intervals are usual. Our dental hygiene service supports this.

• Prompt reporting of any exposed bone, non-healing ulcer, numbness or persistent pain. These require assessment without delay.

• Avoiding elective extractions in irradiated fields where alternatives exist, and ensuring any necessary extraction is planned with the oncology team.

The NHS provides general information about dental implants at nhs.uk.

Seek an assessment if:

• You have completed head or neck radiotherapy and are considering replacing missing teeth.

• You have been advised that implants are not possible and would like a second clinical opinion with your radiotherapy records available.

• You have persistent dry mouth and are noticing new decay or sensitivity.

• You have an area of gum that has not healed, or bone that appears exposed — this warrants urgent assessment.

• An existing denture is causing sore spots or ulceration on irradiated tissue.

• You have an existing implant that has become sore, mobile, or has developed a discharge.

Bring, or arrange for your dental team to request, the radiotherapy treatment summary including the dose and the fields treated. Planning without this information is guesswork.

• Previous head or neck radiotherapy is a significant modifying factor for implant treatment, not an automatic exclusion.

• Radiation reduces blood supply and cell turnover in bone, and causes soft tissue fibrosis and reduced saliva.

• Osteoradionecrosis is the principal serious risk associated with surgery in irradiated bone.

• The radiation dose delivered to the specific site is the most important planning information, and comes from the oncology records.

• The mandible is generally regarded as higher risk than the maxilla.

• Smoking substantially increases risk and cessation is generally required before surgery is considered.

• Protocols are typically modified: careful site selection, extended healing, atraumatic surgery, limited grafting and cleanable prosthesis design.

• Removable prostheses remain a legitimate and sometimes preferable option.

• Decisions should be made jointly with the oncology team, not by the dental team alone.

The honest position is that implants after head and neck radiotherapy sit in a genuinely grey area. Some patients are reasonable candidates with modified planning and close monitoring; for others the balance of benefit and risk points towards a non-surgical solution. What separates those two groups is information — the dose map, current imaging, the state of the soft tissue, and a frank discussion between the dental and oncology teams.

If you have had radiotherapy to the head or neck and would like to discuss your options for replacing missing teeth, you can arrange an appointment with our team at 22 Wimpole St, London W1G 8GQ, or telephone 020 7183 0692.

Dental symptoms and treatment options should always be assessed individually during a clinical examination.

This article is for general educational information only and is not professional dental advice, diagnosis, or a treatment recommendation. Information here is general and cannot replace an in-person assessment by a qualified, GDC-registered dental professional. Symptoms, suitability, fees, timelines, and outcomes vary according to individual clinical circumstances. If you have pain, swelling, or other concerning symptoms, seek prompt professional dental care. Always request a written treatment plan and cost estimate before proceeding with treatment.

Written Date: 24 August 2026

Next Review Date: 24 August 2027